2026 Brian G. Feagan: Medicine Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	National Ranking	Publications	Citations
Medicine	142	1537	49	980	98605

Research.com Recognitions

2023 - Research.com Medicine in Canada Leader Award

Overview

Brian G. Feagan is a researcher affiliated with the University of Western Ontario in Canada. Their work is primarily situated in the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a strong focus on subfields such as Genetics, Epidemiology, Surgery, Immunology, and Oncology.

The main topics in their research include Inflammatory Bowel Disease, Microscopic Colitis, Eosinophilic Esophagitis, Autoimmune and Inflammatory Disorders, Immunodeficiency and Autoimmune Disorders, Helicobacter pylori-related gastroenterology studies, and Chronic Lymphocytic Leukemia Research.

The scientist has contributed to several notable publications, particularly in leading medical journals. Recent papers authored or co-authored by them include:

Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial, 2021, The Lancet

Other influential papers from their field of work, though authored by frequent collaborators, include:

Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis, 2021, New England Journal of Medicine
Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials, 2022, The Lancet
Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn's Disease, 2020, Gastroenterology
Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies, 2023, The Lancet

They frequently collaborate with several other researchers in the gastroenterology and immunology fields. Notable co-authors include:

William J. Sandborn
Bruce E. Sands
Laurent Peyrin-Biroulet
Geert D'Haens
Silvio Danese

The scientist regularly publishes in leading journals relevant to their specialty, such as:

Gastroenterology
Journal of Crohn's and Colitis
The American Journal of Gastroenterology
Clinical Gastroenterology and Hepatology
Alimentary Pharmacology & Therapeutics

Best Publications

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Stephen B Hanauer;Brian G Feagan;Gary R Lichtenstein;Lloyd F Mayer

5145
Citations
Infliximab for induction and maintenance therapy for ulcerative colitis.

Paul Rutgeerts;William J Sandborn;Brian G Feagan;Walter Reinisch

4536
Citations
Vedolizumab as induction and maintenance therapy for ulcerative colitis.

Brian G Feagan;Paul Rutgeerts;Bruce E Sands;Stephen Hanauer

2736
Citations
Infliximab Maintenance Therapy for Fistulizing Crohn's Disease

Bruce E. Sands;Frank H. Anderson;Charles N. Bernstein;William Y. Chey

2688
Citations
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease

William J. Sandborn;Brian G. Feagan;Paul Rutgeerts;Stephen Hanauer

2472
Citations
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.

L. Peyrin-Biroulet;W. Sandborn;B. E. Sands;W. Reinisch;W. Reinisch

1770
Citations
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial

Wolfgang Hueber;Bruce E Sands;Steve Lewitzky;Marc Vandemeulebroecke

1619
Citations
A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis.

Geert D’Haens;William J. Sandborn;Brian G. Feagan;Karel Geboes

1585
Citations
Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis

William J. Sandborn;Chinyu Su;Bruce E. Sands;Geert R. D’Haens

1579
Citations
Certolizumab pegol for the treatment of Crohn’s disease:

William J. Sandborn;Brian G. Feagan;Simeon Stoinov;Pieter J. Honiball

1568
Citations
Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial

Geert D'Haens;Filip Baert;Gert van Assche;Philip Caenepeel

1467
Citations
SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease

Loren Laine;Loren Laine;Tonya Kaltenbach;Alan Barkun;Kenneth R. McQuaid

1296
Citations
Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease

William J. Sandborn;Christopher Gasink;Long Long Gao;Marion A. Blank

1287
Citations
Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease.

Paul Rutgeerts;Brian G. Feagan;Gary R. Lichtenstein;Lloyd F. Mayer

1206
Citations
Serious Infections and Mortality in Association With Therapies for Crohn’s Disease: TREAT Registry

Gary R. Lichtenstein;Brian G. Feagan;Russell D. Cohen;Bruce A. Salzberg

1115
Citations
Natalizumab induction and maintenance therapy for Crohn's disease.

William J. Sandborn;Jean Frédéric Colombel;Roberts Enns;Brian G. Feagan

1045
Citations
Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin.

Brian G Feagan;Gordon R Greenberg;Gary Wild;Richard N Fedorak

1015
Citations
Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis

Jean Frédéric Colombel;Paul Rutgeerts;Walter Reinisch;Dirk Esser

1007
Citations
Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis.

William J Sandborn;Brian G Feagan;Colleen W Marano;Hongyan Zhang

985
Citations
A Controlled Trial of a Critical Pathway for Treatment of Community-Acquired Pneumonia

Thomas J. Marrie;Catherine Y. Lau;Susan L. Wheeler;Cindy J. Wong

979
Citations

Frequent Co-Authors

William J. Sandborn University of California, San Diego

Paul Rutgeerts KU Leuven

Jean-Frederic Colombel Icahn School of Medicine at Mount Sinai

Bruce E. Sands Icahn School of Medicine at Mount Sinai

Geert R. D'Haens University of Amsterdam

Walter Reinisch Medical University of Vienna

Stephen B. Hanauer Northwestern University

Severine Vermeire KU Leuven

Remo Panaccione University of Calgary

Stefan Schreiber Kiel University

External Links

Personal website of Brian G. Feagan

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

Aspiring medical professionals have more flexible education options than ever before, thanks to online degree programs in key healthcare fields. For those interested in nursing, several affordable pathways exist, each catering to a variety of backgrounds and career aspirations.

Current registered nurses can pursue advanced academic roles by enrolling in doctorate in nursing education online programs to prepare for teaching, research, or leadership careers. If you’re looking to enhance your nursing credentials without a large financial burden, check out the cheapest rn to bsn online programs.

For those considering a career pivot, there are online msn programs for non nurses that allow individuals from non-nursing backgrounds to quickly transition into nursing at an advanced level. Alternatively, individuals without prior nursing experience can start their journey with online adn programs for non nurses, providing a foundational entry point into the healthcare field.

With these diverse and accessible online options, students can find a program that matches their needs—whether aiming for clinical practice, education, or administration in medicine and healthcare.